These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17210079)

  • 1. Buprenorphine versus dihydrocodeine for opiate detoxification in primary care: a randomised controlled trial.
    Wright NM; Sheard L; Tompkins CN; Adams CE; Allgar VL; Oldham NS
    BMC Fam Pract; 2007 Jan; 8():3. PubMed ID: 17210079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) prisons project: a randomised controlled trial comparing dihydrocodeine and buprenorphine for opiate detoxification.
    Sheard L; Wright NM; El-Sayeh HG; Adams CE; Li R; Tompkins CN
    Subst Abuse Treat Prev Policy; 2009 Feb; 4():1. PubMed ID: 19196468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) project: an open-label pragmatic randomised control trial comparing the efficacy of differing therapeutic agents for primary care detoxification from either street heroin or methadone [ISRCTN07752728].
    Oldham NS; Wright NM; Adams CE; Sheard L; Tompkins CN
    BMC Fam Pract; 2004 Apr; 5():9. PubMed ID: 15117415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydrocodeine for detoxification and maintenance treatment in individuals with opiate use disorders.
    Carney T; Van Hout MC; Norman I; Dada S; Siegfried N; Parry CD
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD012254. PubMed ID: 32068247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of methadone and buprenorphine for opiate detoxification (LEEDS trial): a randomised controlled trial.
    Wright NM; Sheard L; Adams CE; Rushforth BJ; Harrison W; Bound N; Hart R; Tompkins CN
    Br J Gen Pract; 2011 Dec; 61(593):e772-80. PubMed ID: 22137413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) prisons project pilot study: protocol for a randomised controlled trial comparing dihydrocodeine and buprenorphine for opiate detoxification.
    Sheard L; Adams CE; Wright NM; El-Sayeh H; Dalton R; Tompkins CN
    Trials; 2007 Jan; 8():1. PubMed ID: 17210080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization characteristics and treatment persistence in patients prescribed low-dose buprenorphine patches in primary care in the United Kingdom: a retrospective cohort study.
    Gallagher AM; Leighton-Scott J; van Staa TP
    Clin Ther; 2009 Aug; 31(8):1707-15. PubMed ID: 19808129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) Prisons Project Study: protocol for a randomised controlled trial comparing methadone and buprenorphine for opiate detoxification.
    Sheard L; Wright NM; Adams CE; Bound N; Rushforth B; Hart R; Tompkins CN
    Trials; 2009 Jul; 10():53. PubMed ID: 19602218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addressing the efficacy of dihydrocodeine versus methadone as an alternative maintenance treatment for opiate dependence: A randomized controlled trial.
    Robertson JR; Raab GM; Bruce M; McKenzie JS; Storkey HR; Salter A
    Addiction; 2006 Dec; 101(12):1752-9. PubMed ID: 17156174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prescribing of methadone and other opioids to addicts: national survey of GPs in England and Wales.
    Strang J; Sheridan J; Hunt C; Kerr B; Gerada C; Pringle M
    Br J Gen Pract; 2005 Jun; 55(515):444-51. PubMed ID: 15970068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of buprenorphine and lofexidine for community opiate detoxification: results from a randomized controlled trial.
    Raistrick D; West D; Finnegan O; Thistlethwaite G; Brearley R; Banbery J
    Addiction; 2005 Dec; 100(12):1860-7. PubMed ID: 16367987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deaths of opiate/opioid misusers involving dihydrocodeine, UK, 1997-2007.
    Zamparutti G; Schifano F; Corkery JM; Oyefeso A; Ghodse AH
    Br J Clin Pharmacol; 2011 Aug; 72(2):330-7. PubMed ID: 21235617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bridging waitlist delays with interim buprenorphine treatment: initial feasibility.
    Sigmon SC; C Meyer A; Hruska B; Ochalek T; Rose G; Badger GJ; Brooklyn JR; Heil SH; Higgins ST; Moore BA; Schwartz RP
    Addict Behav; 2015 Dec; 51():136-42. PubMed ID: 26256469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone.
    Fudala PJ; Bridge TP; Herbert S; Williford WO; Chiang CN; Jones K; Collins J; Raisch D; Casadonte P; Goldsmith RJ; Ling W; Malkerneker U; McNicholas L; Renner J; Stine S; Tusel D;
    N Engl J Med; 2003 Sep; 349(10):949-58. PubMed ID: 12954743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initiating buprenorphine treatment for opioid use disorder during short-term in-patient 'detoxification': a randomized clinical trial.
    Stein M; Herman D; Conti M; Anderson B; Bailey G
    Addiction; 2020 Jan; 115(1):82-94. PubMed ID: 31430414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence.
    Schottenfeld RS; Chawarski MC; Pakes JR; Pantalon MV; Carroll KM; Kosten TR
    Am J Psychiatry; 2005 Feb; 162(2):340-9. PubMed ID: 15677600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medically assisted recovery from opiate dependence within the context of the UK drug strategy: methadone and Suboxone (buprenorphine-naloxone) patients compared.
    McKeganey N; Russell C; Cockayne L
    J Subst Abuse Treat; 2013 Jan; 44(1):97-102. PubMed ID: 22703715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydrocodeine: a useful tool in the detoxification of methadone-maintained patients.
    Banbery J; Wolff K; Raistrick D
    J Subst Abuse Treat; 2000 Oct; 19(3):301-5. PubMed ID: 11027902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trial.
    Gibson AE; Doran CM; Bell JR; Ryan A; Lintzeris N
    Med J Aust; 2003 Jul; 179(1):38-42. PubMed ID: 12831383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study protocol of the ESUB-MG cluster randomized trial: a pragmatic trial assessing the implementation of urine drug screening in general practice for buprenorphine maintained patients.
    ESUB-MG Study Group
    BMC Fam Pract; 2016 Mar; 17():24. PubMed ID: 26931763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.